In mice, blocking heart-to-brain signals improved healing after a heart attack, hinting at new targets for cardiac therapy.
Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...
A Tokyo-based startup said transplants of cardiac muscle cells that it engineered from induced pluripotent stem (iPS) cells ...
University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse ...
When the heart's muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood ...
Maintaining a stable heartbeat is critical for survival. Your heart must constantly adapt its output to meet changing demands ...
Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...
Acute inflammation is a physiological and host defense response to cardiac injury after suffering myocardial infarction (MI), which programmes cardiac repair and wound healing. Leukocyte-mediated ...
SGMC Health is expanding its advanced cardiac imaging capabilities with the introduction of Positron Emission Tomography (PET) cardiac stress testing, offering patients faster, more accurate ...
John Barrass, 78, is successfully treated at Sheffield's Northern General Hospital.